Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.

NCT05331469 is registered in ClinicalTrials.gov with University of Malaya as lead sponsor.

NCT NCT05331469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.
Lead sponsor
University of Malaya
Phase
Phase 4
Overall status
Unknown status
Start date
July 19, 2021
Completion date
April 30, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to identify which titration regimen of basal insulin (being daily titration vs 3 daily titration) is better in reducing hba1c and have lesser hypoglycemia